Source Intelligence Evolves With C-Map: Delivering Next-Generation SaaS Platform for Compliance & Sustainability
4.11.2024 11:00:00 CET | ACCESS Newswire | Press release
The platform delivers faster risk identification, seamless data access, and streamlined workflows
SAN DIEGO, CA / ACCESSWIRE / November 4, 2024 / Source Intelligence has evolved with C-Map, a next-generation software as a service (SaaS) platform that empowers enterprises to manage compliance and sustainability with greater efficiency. Designed to address the increasing complexities of today's regulatory landscape, this powerful platform combines robust automation capabilities, Artificial Intelligence (AI), and in-house regulatory expertise to help companies tackle increasing compliance demands and mitigate emerging risks.
Source Intelligence's logo and tagline - "Trust Your Source"
With regulations evolving faster than ever, compliance teams often struggle with limited resources. Collecting supplier data, responding to documentation requests, and keeping up with shifting requirements create considerable challenges. C-Map reduces manual effort, streamlines workflows, and equips businesses with tools to mitigate risk. These efficiencies translate into tangible outcomes, including:
Rapid risk identification: AI capabilities improve data quality and deliver insights into key risk areas faster. This offers companies better visibility and a stronger return on investment.
Enhanced risk mitigation through precise data collection: Expert-designed templates and assessments help standardize data collection. This allows teams to make informed decisions and address potential risks before they escalate.
Seamless data access with integrated compliance tools: A world-class database integrates with ERP, PLM, and warehousing systems. These integrations enable seamless data exchange, automate compliance checks, and offer real-time visibility into supply chain activities.
Increased efficiency through streamlined workflows: Automated workflows ease internal workloads, enabling businesses to manage compliance and sustainability without relying on consulting or manual labor.
Faster customer request fulfillment: Automated report and declaration generation reduces manual work. This helps companies respond to customer requests quickly and meet demand effectively.
Together, these outcomes empower businesses to reduce risk, enhance efficiency, and maintain control over compliance in a dynamic regulatory environment.
"C-Map represents a significant step forward for Source Intelligence," said Mike Flynn, Chief Product Officer of Source Intelligence. "We recognized that the only way to help businesses tackle increasingly complex regulations was to deliver a platform that offers scalability, flexibility, and automation. Our software is trusted by some of the world's largest and most sophisticated companies to manage compliance at the highest levels, proving its reliability and impact."
With enhanced visibility and control over compliance tasks, businesses across industries - including electronics, medical devices, and industrial manufacturing - can confidently navigate evolving regulations. C-Map offers the flexibility to be self-managed or paired with managed services for additional support. Interested organizations are invited to schedule a demo and experience the platform firsthand.
About Source Intelligence
Source Intelligence simplifies compliance, sustainability, and ESG management through scalable SaaS solutions and managed services, configurable to meet the unique needs of any enterprise. For more information, please visit www.sourceintelligence.com.
Contact Information
Amanda Lindberg
Director of Marketing
amanda.lindberg@sourceintel.com
SOURCE: Source Intelligence
View the original press release on newswire.com.
Source Intelligence

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
Formerra and Evonik Expand Distribution Partnership for Healthcare Grades2.2.2026 15:00:00 CET | Press release
Agreement Expands Access to Evonik's CARE Brand Medical Grades in the U.S. and Canada ROMEOVILLE, ILLINOIS / ACCESS Newswire / February 2, 2026 / Formerra, a leader in performance materials distribution, today announced an expanded distribution agreement that brings Evonik's CARE brand healthcare grades into Formerra's medical portfolio. Covering the United States and Canada, the agreement creates new access points for high-performance polyamides used in essential healthcare applications. This expansion kicks off at MD&M West 2026 this week, and underscores both companies' commitment to supporting the healthcare market with high-performance materials, responsive service, and continuity of supply. It also builds on the companies' two-year partnership, which introduced Evonik's VESTAMID® and TROGAMID® families to Formerra's engineered materials lineup. With this expansion, Formerra will support Evonik healthcare grades designed for fluid handling, drug delivery, diagnostic systems, surgi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom